GLP Watchdog

Brello Health vs Hims

Hims has an open FDA warning letter dated September 9, 2025. Brello Health has none. No price lines up like for like: Brello Health and Hims publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Brello Health / Hims

Brello Health logo

Brello Health

8.1/10

Hims logo

Hims

6.7/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$157.72/moCompounded semaglutide injection, 3-month prepaid plan
$149/moBrand-name semaglutide pill, medication only, membership extra
States
40 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Brello Health
Visit Hims

Neither Brello Health nor Hims pays us. Links to them earn nothing. Scores: Brello Health 8.1, Hims 6.7. How we are paid

What the record shows

  1. 01

    Hims has an open FDA warning letter dated September 9, 2025. Brello Health has none.

  2. 02

    Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Hims sells brand-name medication only.

  3. 03

    No price lines up like for like: Brello Health and Hims publish prices for different products.

  4. 04

    Only Brello Health lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only Hims lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    Hims covers 10 states Brello Health does not.

  6. 06

    Brello Health holds you to a 3-month prepay (6-month plan optional); Hims states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Brello Health

Hims

Compounded semaglutide injection

$157.72/mo

3-month prepaid plan; not compared

Not sold or not priced
Compounded tirzepatide injection

$176.69/mo

6-month prepaid plan; not compared

Not sold or not priced
Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
No
Yes, stated
Minimum term
3-month prepay (6-month plan optional)
Monthly membership, auto-renews
Refunds
Full refund before a prescription; $50 fee within 24 hours after; none once dispensed
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Brello Health: October 25, 2026. Hims: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Brello Health

8.1/10
  • No FDA warning letter on record
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Hims does not price
  • Price includes clinician visits
  • Minimum commitment before you can cancel
  • Lowest price is a 3-month prepaid rate
Visit Brello Health

The case for Hims

6.7/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Brello Health does not price
  • Lists 50 states against 40
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

Scores

Brello Health 8.1 · Hims 6.7 out of 10. Six weighted parts.

Value25%

6.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

10.0A
vs
B
6.0

Accessibility10%

8.4A
vs
B
10.0

Support10%

5.5A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Brello Health vs Hims: questions

Hims has an open FDA warning letter dated September 9, 2025. Brello Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Hims sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: Brello Health and Hims publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Brello Health has a minimum term (3-month prepay (6-month plan optional)). Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed.
Neither Brello Health nor Hims pays us. Links to them earn nothing. Scores: Brello Health 8.1, Hims 6.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks